Unlocking the Potential of Targeting the Innate Immune System
Evaluating the Inflammasome Multi-Protein Complex for Therapeutic Targeting, Connecting Proof-of-Concept Biomarkers & Disease Endpoints & Assessing Combination Therapy to Achieve Clinical Efficacy
Now in its 7th year, the Inflammasome Therapeutics Summit is the only industry forum focused exclusively on inflammasome-targeted drug development. Join 70+ experts from discovery to clinic, including leading drug developers, translational scientists, and clinical strategists to:
- Share insights and benchmark progress across neuroinflammation, metabolic, and autoimmune indications
- Dive into the latest clinical data, emerging mechanisms, and translational breakthroughs
- Connect with those driving the field forward and shape the next wave of innovation
Join your peers to hear directly from those driving programs forward, tackle the most pressing translational challenges, and help chart the future of inflammasome therapeutics.
Explore the 2025
Full Event Guide
2025 Expert Speakers Include:
Companies in the Room Include:
Poster Session
Applications are now open for this year's poster session - an exclusive opportunity to share what you are currently working on, allowing you to demonstrate your thought leadership, gain visibility and exposure in showcasing your innovations and engage in meaningful discussions with industry peers.
2025 Partners
